Indeed, the depletion of liver Socs3, the negative regulator of Stat3 activation, has been shown to promote hepatic lipogenesis and the development of NAFLD under DIO [13, 38]. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatotic liver disease.